Sinai Health LTRI Seminar

Organised in collaboration with:
Thermo Fisher Scientific - Red BG

Unlocking the power of proteomics

Date: Tuesday, May 12th, 2026 

Time: 12:00 – 1:00 PM

Location:  Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute
60 Murray Street, Room L3-201 

(food and refreshments provided)

Regsitration is now closed

Join Us for an Exclusive In-Person Seminar

Step into the new era of proteomics with Olink and discover how our technology is transforming multiomics and translational research.

During this seminar, we will explore how Olink is enabling high-impact discoveries across a wide range of disease areas, and why it was selected as the proteomics platform for the UK Biobank Pharma Proteomics Project—the world’s largest proteogenomics initiative, aiming to profile 5,400 proteins across 600,000 samples.

We will also highlight Olink’s expanding portfolio, including: 

- Olink Reveal - a scalable, accessible solution for broad proteomic profiling

-Olink Explore HT - enabling deep, high throughput discovery

-New Olink Neurodegeneration Panel - designed to advance research into neurodegenerative diseases with targeted high-sensitivity protein measurment

Whether you are new to proteomics or looking to expand your current workflows, this session will provide practical insights into integrating proteomics into your research with ease and impact.

Agenda 

 

Welcome - Mariam Iskilova, Sinai Health, LTRI, Laboratory Manager  High-Throughput Screening Facility (5 min)

 

Introduction to Olink - Sean Wells, Olink Sales Specialist (10 mins)

 

Guest Speaker - Williams Turpin, PhD, Translational Research Scientist. Assistant Professor, Temerty Faculty of Medicine at the University of Toronto, Department of Nutritional Sciences - Mount Sinai Hospital, Joseph and Wolf Lebovic Health Complex, Zane Cohen Centre for Digestive Diseases (20 min)

 

Olink Technical Insights - Madison Barrett, Olink Field Application Scientist (15 min)

Presentation Details

Deciphering the effect of diet on molecular markers of health and disease   

Abstract:

Epidemiological evidence increasingly supports diet as a key contributor to human health and disease. Specific components of diet, such as lipids, dietary fiber, and the degree of food processing can significantly influence disease risk.

In this presentation, I will highlight molecular pathways that can be modulated through dietary strategies to help prevent disease onset. Focusing on Crohn’s disease as a case study, I will illustrate how diet can shape disease risk and identify potential targets for prevention.

Advances in multi-omics approaches, spanning proteomics to microbiomics, are rapidly transforming our understanding of disease pathogenesis and revealing how diet interacts with the host and gut microbiome at an unprecedented level of detail.

    Williams Turpin 

Dr. Williams Turpin

Assistant Professor of Nutritional Science at the University of Toronto,                        Translational Research Scientist, Mount Sinai Hospital                          

Dr Turpin's research centers on the intersection of diet, the gut microbiome and immune-mediated disease, with a strong emphasis on proteomics and multi-omic approaches to better understand disease mechanisms. His work explores how nutritional factors - such as lipids, dietary fiber, and levels of food processing - influence molecular pathways involved in conditions like inflammatory bowel disease, with the goal of advancing strategies for disease prevention and management.

Using advanced proteomics and integrative multi-omics, Dr Turpin investigates how dietary patterns shape microbial function alter host protein expression, and modulate inflammatory responses. His research is highly translational, bridging mechanistic discovery with clinically relevant applications including personalised nutrition and targeted interventions

In this presentation he will highlight how diet can modulate key molecular pathways to help prevent disease onset, using Crohn's disease as a case study to demonstrate how dietary factors influence disease risk and reveal potential targets for prevention. He will also discuss how advances in multi-omics, from proteomics to microbiomics, are transforming our understanding of disease pathogenesis and enabling deeper insights into host-microbiome interactions. 

Through close collaboration with clinicians and dietitians, Dr Turpin ensures his work remains directly applicable to patient care and real-world health strategies. 

Use the contact details below if you would like more information

Sean Wells

Sales Specialist - Ontario

Proteomic Sciences

Olink, part of Thermo Fisher Scientific

Tel: 437-688-5040 | Sean.Wells@olink.com